NHS England procurement for the supply of Hepatitis C treatments and the provision of Hepatitis C elimination initiatives

NHS England

This public procurement record has 1 release in its history.

AwardUpdate

15 Mar 2024 at 11:55

Summary of the contracting process

The NHS England procurement is for the supply of Hepatitis C treatments and the provision of Hepatitis C elimination initiatives. The buying organisation is NHS England, and the procurement is classified under pharmaceutical products. It is in the goods procurement category and is being conducted by NHS Arden & Greater East Midlands Commissioning Support Unit on behalf of NHS England. The contract period is from 1st May 2019 to 31st March 2024. The procurement method is a tender, and the current stage is the award stage. The successful supplier for this tender is Merck Sharpe and Dohme (UK) Limited.

This tender provides opportunities for businesses involved in the supply of Hepatitis C treatments and services related to Hepatitis C elimination initiatives. Businesses with Direct Acting Antiviral (DAA) products for Hepatitis C treatment are well-suited to compete. The procurement is aimed at organisations that can accelerate the elimination of Hepatitis C in England. Interested parties must engage through the NHS Arden & Greater East Midlands Commissioning Support Unit e-procurement portal. The contract is active, with a value of £1.2 billion GBP. The duration of the contract is initially three years, with possible extensions up to two additional years.

How relevant is this notice?

Notice Title

NHS England procurement for the supply of Hepatitis C treatments and the provision of Hepatitis C elimination initiatives

Notice Description

Lot Information

Lot 1

This procurement will be conducted by NHS Arden & Greater East Midlands Commissioning Support Unit on behalf of NHS England Specialised Commissioning.
Contract(s) entered into pursuant to this procurement will be between the successful supplier(s) and NHS England (National Health Service Commissioning Board).
Organisations wishing to participate in the procurement must have at least one Direct Acting Antiviral (DAA) for the treatment of Hepatitis C within their product portfolio. There is no restriction on the number of DAA products that bidders can offer for, or that can be included in the contract(s).
Contract(s) awarded pursuant the procurement exercise are for use by the Department of Health, Public Health England, the NHS in England; and be used by private sector contractors and agents working on behalf of the aforementioned
Appointed suppliers will be responsible for (i) the supply of Hepatitis C DAA treatments and (ii) the provision of Hepatitis C elimination initiatives and/or services to help identify and treat Hepatitis C patients so as to accelerate the elimination of Hepatitis C in England from 1st October 2018. The duration of any Contract(s) awarded will be for an initial period of three (3) years, with an option to extend (at the sole discretion of the contracting authority) for an additional period or periods up to two (2) years.
Further information, including details regarding the Lots, is set out in the procurement documents which are available to download (see below for details)
The contracting authority intends to use the NHS Arden & Greater East Midlands Commissioning Support Unit e-procurement portal in this procurement exercise.
i) To Register - log onto the portal at https://ardengemcsu.bravosolution.co.uk (registration and use of the website is free of charge).
ii) Express interest by:
a) selecting response to advert and PQQ (ref: pqq_483) and ITT (ref: itt_958)
b) select Open Access ITT
c) search for and access listing related to this contract and view details
d) click on Express Interest link
iii) Once you have expressed interest, access the My ITTs page where you can download and complete the ITT.

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-04490c
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/008381-2024
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Not Specified
Procurement Method Details
Not specified
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
£1,200,000,000 £1B-£10B

Notice Dates

Publication Date
15 Mar 20242 years ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
1 May 20197 years ago
Contract Period
1 May 2019 - 31 Mar 2024 4-5 years
Recurrence
Not specified

Notice Status

Tender Status
Not Specified
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LEEDS
Postcode
LS1 4AP
Postcode Area
Leeds
Country
England

Major Region (ITL 1)
TLE Yorkshire and The Humber
Basic Region (ITL 2)
TLE4 West Yorkshire
Small Region (ITL 3)
TLE42 Leeds
Delivery Location
Not specified

Local Authority
Leeds
Electoral Ward
Hunslet & Riverside
Westminster Constituency
Leeds South

Supplier Information

Number of Suppliers
1
Supplier Name

Merck Sharpe and Dohme (UK) Limited

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...